Erratum: High-background parenchymal enhancement in the contralateral breast is an imaging biomarker for favorable prognosis in patients with triple-negative breast cancer treated with chemotherapy
Am J Transl Res. 2023 Jul 15;15(7):4970.
eCollection 2023.